Similar articles

• Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.

  Patmasiriwat P, Bhothisuwan K, Sinilnikova OM, Chopin S, Methakijvaroon S, Badzioch M, Padungsutt P, Vattanaviboon P, Vattanasapt V, Szabo C, Saunders GF, Goldgar D, Lenoir GM. Patmasiriwat P, et al. Hum Mutat. 2002 Sep;20(3):230. doi: 10.1002/humu.9049. Hum Mutat. 2002. PMID: 12203997
• Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

  Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K. Satagopan JM, et al. Clin Cancer Res. 2002 Dec;8(12):3776-81. Clin Cancer Res. 2002. PMID: 12473589
• Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.

  van der Kolk DM, de Bock GH, Leegte BK, Schaapveld M, Mourits MJ, de Vries J, van der Hout AH, Oosterwijk JC. van der Kolk DM, et al. Breast Cancer Res Treat. 2010 Dec;124(3):643-51. doi: 10.1007/s10549-010-0805-3. Epub 2010 Mar 4. Breast Cancer Res Treat. 2010. PMID: 20204502
• Breast cancer susceptibility testing: past, present and future.

  Goldberg JI, Borgen PI. Goldberg JI, et al. Expert Rev Anticancer Ther. 2006 Aug;6(8):1205-14. doi: 10.1586/14737140.6.8.1205. Expert Rev Anticancer Ther. 2006. PMID: 16925486 Review.
• BRCA1 and BRCA2 mutations in breast and ovarian cancer syndrome: reflection on the Creighton University historical series of high risk families.

  Sinilnikova OM, Mazoyer S, Bonnardel C, Lynch HT, Narod SA, Lenoir GM. Sinilnikova OM, et al. Fam Cancer. 2006;5(1):15-20. doi: 10.1007/s10689-005-2571-7. Fam Cancer. 2006. PMID: 16528604 Review.